Identifying potential prognosis markers in relapsed multiple myeloma via integrated bioinformatics analysis and biological experiments
{{output}}
Background: Almost all multiple myeloma (MM) patients will eventually develop disease that has relapsed with or become refractory to current therapeutic regimes. However, the pervious clinical parameters have been proved inaccura... ...
